Feduska NJ - Search Results

1

Are blood transfusions beneficial in the cyclosporine era?

Potter DE, Portale AA, Melzer JS, Feduska NJ, Garovoy MR, Husing RM, Salvatierra O Jr. Potter DE, et al. Among authors: feduska nj. Pediatr Nephrol. 1991 Jan;5(1):168-72. doi: 10.1007/BF00852877. Pediatr Nephrol. 1991. PMID: 2025530 Clinical Trial.

2

Inability of cyclosporine to completely prevent the recurrence of focal glomerulosclerosis after kidney transplantation.

Vincenti F, Biava C, Tomlanovitch S, Amend WJ Jr, Garovoy M, Melzer J, Feduska N, Salvatierra O Jr. Vincenti F, et al. Transplantation. 1989 Apr;47(4):595-8. doi: 10.1097/00007890-198904000-00006. Transplantation. 1989. PMID: 2650043

3

"Anti-idiotypic" antibodies to HLA in transiently sensitized DST patients.

Pohanka E, Manfro RC, Oto C, Colombe BW, Melzer JS, Feduska N, Salvatierra O Jr, Garovoy MR. Pohanka E, et al. Hum Immunol. 1989 Sep;26(1):17-26. doi: 10.1016/0198-8859(89)90029-3. Hum Immunol. 1989. PMID: 2674072

4

Has cyclosporine really relegated pretransplant blood transfusions to therapeutic obsolescence?

Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O Jr. Melzer JS, et al. Among authors: feduska nj. Transplant Proc. 1987 Feb;19(1 Pt 3):1971-3. Transplant Proc. 1987. PMID: 2856274 No abstract available.

5

Cyclosporine provides better success rates for both higher- and lower-risk cadaveric kidney transplant recipients.

Feduska NJ, Melzer JS, Amend WJ Jr, Vincenti F, Tomlanovich SJ, Garovoy M, Husing R, Salvatierra O Jr. Feduska NJ, et al. Transplant Proc. 1988 Jun;20(3 Suppl 3):102-9. Transplant Proc. 1988. PMID: 3291212 No abstract available.

6

The beneficial effect of pretransplant blood transfusions in cyclosporine-treated cadaver renal allograft recipients.

Melzer JS, Husing RM, Feduska NJ, Tomlanovich SJ, Vincenti F, Amend WJ, Garovoy M, Salvatierra O Jr. Melzer JS, et al. Among authors: feduska nj. Transplantation. 1987 Jan;43(1):61-4. doi: 10.1097/00007890-198701000-00014. Transplantation. 1987. PMID: 3541325

7

Donor-specific blood transfusions versus cyclosporine--the DST story.

Salvatierra O Jr, Melzer J, Vincenti F, Amend WJ Jr, Tomlanovich S, Potter D, Husing R, Garovoy M, Feduska NJ. Salvatierra O Jr, et al. Among authors: feduska nj. Transplant Proc. 1987 Feb;19(1 Pt 1):160-6. Transplant Proc. 1987. PMID: 3547813

8

Anti-idiotypic antibodies to HLA after donor-specific blood transfusion (DST).

Pohanka E, Manfro RC, Oto C, Colombe BW, Melzer J, Feduska N, Salvatierra O Jr, Garovoy MR. Pohanka E, et al. Transplant Proc. 1989 Feb;21(1 Pt 2):1806-9. Transplant Proc. 1989. PMID: 2652590 No abstract available.

9

The incidence and impact of herpes simplex virus infections in the first month following renal transplantation.

Tomlanovich SJ, Sabatte-Caspillo J, Melzer J, Amend W, Vincenti F, Feduska N, Salvatierra O. Tomlanovich SJ, et al. Transplant Proc. 1989 Feb;21(1 Pt 2):2091-2. Transplant Proc. 1989. PMID: 2652674 No abstract available.

10

Is cyclosporine effective in preventing recurrence of immune-mediated glomerular disease after renal transplantation?

Tomlanovich S, Vincenti F, Amend W, Biava C, Melzer J, Feduska N, Salvatierra O. Tomlanovich S, et al. Transplant Proc. 1988 Jun;20(3 Suppl 4):285-8. Transplant Proc. 1988. PMID: 3289209 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters